SCHEMBL2107907

SCHEMBL2107907

COC(=O)c1ccc(CC(C(=O)Nc2ccccc2)C(=O)Nc2ccccc2)cc1Br

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
GAA P10253 2/20 0.51
HDAC1 Q13547 1/20 0.45
TP53 P04637 1/20 0.45
KMT2A Q03164 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 2/20 0.44
LMNA P02545 2/20 0.44
USP2 O75604 1/20 0.44
MAPT P10636 1/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
HIF1A Q16665 2/20 0.43
KDM4E B2RXH2 1/20 0.43
AVPR2 P30518 1/20 0.42
GPR27 Q9NS67 1/20 0.42
NPY1R P25929 1/20 0.41
NPY2R P49146 1/20 0.41
F2R P25116 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753692 0.82 ALDH1A1 (0.43) ALDH1A1GAAHDAC1TP53KMT2A
SCHEMBL2107693 0.79 HDAC1 (0.70) HDAC1KMT2AMEN1LMNANPC1
SCHEMBL28479693 0.76 KDM4E (0.53) ALDH1A1GAAKMT2ALMNAMAPT
SCHEMBL13182869 0.74 ALDH1A1 (0.47) ALDH1A1GAATP53KMT2ASMN1; SMN2
SCHEMBL14853314 0.73 HDAC1 (0.61) ALDH1A1HDAC1TP53KMT2AMEN1
SCHEMBL31541719 0.73 THRB (0.47) ALDH1A1GAALMNAMAPTHIF1A
SCHEMBL20576855 0.73 KDM4E (0.42) ALDH1A1GAAKMT2ALMNAMAPT
SCHEMBL28569366 0.72 ALDH1A1 (0.37) ALDH1A1GAAKMT2ALMNAMAPT
SCHEMBL29775267 0.72 ALDH1A1 (0.46) ALDH1A1GAAKMT2ASMN1; SMN2MAPT
SCHEMBL1754056 0.72 ALDH1A1 (0.46) ALDH1A1GAAKMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896395-B1 MODIFIED MALONATE DERIVATIVES MERCK SHARP & DOHME (US) 2015-07-15 EP disclosed
US-8158825-B2 Modified malonate derivatives MERCK SHARP & DOHME CORP. (US) 2012-04-17 US disclosed
US-20100160327-A1 Modified Malonate Derivatives MERCK SHARP & DOHME LLC 2010-06-24 US disclosed
EP-1896395-A2 MODIFIED MALONATE DERIVATIVES Merck & Co., Inc. (US) 2008-03-12 EP disclosed
WO-2007002248-A2 MODIFIED MALONATE DERIVATIVES MERCK & CO., INC. (US) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160327-A1 Modified Malonate Derivatives ME2, ME3, ME1 ALDH1A1 784/4885GAA 713/4885HDAC1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.